Complete Filing Data
Polomar Health Services, Inc. reported Net Income Loss of -$1.34 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Polomar Health Services, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Net Income * | -$1.3M | -$588.0K | -$181.1K |
| Operating Income Loss | -$1.3M | -$440.8K | -$181.5K |
| Operating Expenses | $1.3M | $478.4K | $216.0K |
| General And Administrative Expense | $1.3M | $450.5K | $216.0K |
| Gross Profit | $30.9K | $37.6K | $34.5K |
| Nonoperating Income Expense | -$41.8K | -$147.2K | $329.00 |
| Selling And Marketing Expense | $46.0K | $27.9K | |
| Cost Of Revenue | $27.9K | $4.3K | |
| Revenues | $58.8K | $41.8K | $34.5K |
| Interest Expense Nonoperating | $41.8K | $495.00 | |
| Income Loss From Continuing Operations Per Basic Share |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$649.8K | -$605.6K | -$456.9K | -$718.8K | -$271.3K | -$190.7K | -$160.5K | -$127.6K | -$172.2K | -$91.0K | -$89.8K | -$13.4K | -$13.7K | -$2.3K |
| Operating Income Loss | -$628.8K | -$563.3K | -$415.4K | -$259.2K | -$190.7K | -$160.5K | -$134.7K | -$91.0K | -$89.8K | -$13.5K | -$13.7K | |||
| Operating Expenses | $633.1K | $567.2K | $418.6K | $268.0K | $201.0K | $163.2K | $154.6K | $91.0K | $89.8K | $18.0K | $13.7K | |||
| General And Administrative Expense | $619.0K | $556.7K | $398.8K | $256.3K | $186.9K | $149.3K | $147.3K | $91.0K | $89.8K | $18.0K | $13.7K | |||
| Gross Profit | $4.3K | $3.8K | $3.2K | $8.9K | $10.3K | $2.7K | $19.9K | $4.5K | ||||||
| Nonoperating Income Expense | -$21.0K | -$42.2K | -$41.4K | -$12.2K | -$37.5K | $77.00 | ||||||||
| Selling And Marketing Expense | $14.1K | $10.5K | $19.8K | $11.7K | $14.1K | $13.9K | $7.3K | |||||||
| Cost Of Revenue | $1.8K | $1.6K | $1.4K | $985.00 | $4.2K | $10.9K | $1.5K | |||||||
| Revenues | $6.2K | $5.5K | $4.5K | $9.8K | $14.5K | $13.6K | $21.5K | $4.5K | ||||||
| Interest Expense Nonoperating | $21.0K | $42.2K | $41.4K | $12.2K | $37.5K | |||||||||
| Income Loss From Continuing Operations Per Basic Share | $0.00 | $0.00 | -$0.05 | -$0.04 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity * | $186.8K | -$85.1K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $225.6K | |||
| Retained Earnings Accumulated Deficit | -$1.6M | -$981.8K | ||
| Liabilities Current | $102.5K | $74.7K | ||
| Liabilities And Stockholders Equity | $107.1K | $261.5K | ||
| Liabilities | $151.6K | $74.7K | ||
| Common Stock Value | $109.1K | $107.6K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.6K | -$216.8K | $225.6K | |
| Assets Current | $12.3K | $261.5K | ||
| Assets | $107.1K | $261.5K | ||
| Accounts Payable And Accrued Liabilities Current | $39.5K | $5.0K | ||
| Other Assets Noncurrent | $94.8K | |||
| Operating Lease Right Of Use Asset | $81.7K | |||
| Inventory Net | $3.5K | |||
| Preferred Stock Value | $500.00 | $500.00 | ||
| Operating Lease Liability Noncurrent | $49.2K | |||
| Operating Lease Liability Current | $32.5K | |||
| Liabilities Noncurrent | $49.2K | |||
| Property Plant And Equipment Net | ||||
| Property Plant And Equipment Gross | ||||
| Leasehold Improvements | ||||
| Debt Instrument Decrease Forgiveness | $146.6K | |||
| Other Intangible Assets Net | ||||
| Inventory Write Down | -$65.3K | -$3.5K | ||
| Accounts Receivable Net | ||||
| Other Liabilities Current | ||||
| Notes And Loans Payable Current | $69.7K | |||
| Stock Issued During Period Value Conversion Of Preferred Stock | -$500.00 | |||
| Repayments Of Related Party Debt | $112.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $7.8M | $8.4M | $8.1M | $8.6M | $9.3M | -$395.7K | -$205.0K | -$44.5K | $19.2K | $85.3K | $207.2K | $186.8K | -$65.0K | -$51.6K | -$37.9K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $38.9K | $4.7K | $129.3K | $6.2K | $16.2K | $19.9K | $28.0K | $8.8K | $36.5K | $28.0K | $198.3K | ||||
| Retained Earnings Accumulated Deficit | -$4.6M | -$4.0M | -$3.4M | -$2.9M | -$2.2M | -$1.5M | -$1.5M | -$1.3M | -$1.2M | ||||||
| Liabilities Current | $1.5M | $1.0M | $1.7M | $1.3M | $953.8K | $103.0K | $82.8K | $14.9K | $14.0K | ||||||
| Liabilities And Stockholders Equity | $9.3M | $9.4M | $9.8M | $10.0M | $19.3M | $294.00 | $244.00 | $129.0K | $130.2K | ||||||
| Liabilities | $1.5M | $1.0M | $1.7M | $1.4M | $977.4K | $103.0K | $82.8K | $14.9K | $14.0K | ||||||
| Common Stock Value | $28.0K | $27.9K | $27.7K | $27.7K | $27.7K | $109.1K | $109.1K | $109.1K | $108.6K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $123.1K | $19.2K | -$27.3K | ||||||||||||
| Assets Current | $197.7K | $93.1K | $201.2K | $76.8K | $156.1K | $294.00 | $244.00 | $129.0K | $130.2K | ||||||
| Assets | $9.3M | $9.4M | $9.8M | $10.0M | $19.3M | $294.00 | $244.00 | $129.0K | $130.2K | ||||||
| Accounts Payable And Accrued Liabilities Current | $272.3K | $172.1K | $118.3K | $164.9K | $86.3K | $22.8K | $29.7K | $10.2K | $7.7K | ||||||
| Other Assets Noncurrent | $9.0M | $9.3M | $9.5M | $9.8M | $19.0M | ||||||||||
| Operating Lease Right Of Use Asset | $23.6K | $32.3K | $40.8K | $49.2K | $57.5K | ||||||||||
| Inventory Net | $158.8K | $74.4K | $70.0K | $68.8K | $139.9K | ||||||||||
| Preferred Stock Value | $500.00 | $500.00 | $500.00 | $500.00 | |||||||||||
| Operating Lease Liability Noncurrent | $6.0K | $14.9K | $23.6K | ||||||||||||
| Operating Lease Liability Current | $23.6K | $32.3K | $34.8K | $34.3K | |||||||||||
| Liabilities Noncurrent | $6.0K | $14.9K | $23.6K | ||||||||||||
| Property Plant And Equipment Net | $52.9K | $62.4K | $71.9K | $81.4K | $87.7K | ||||||||||
| Property Plant And Equipment Gross | $41.5K | $41.5K | $41.5K | $41.5K | $41.5K | ||||||||||
| Leasehold Improvements | $49.4K | $49.4K | $49.4K | $49.4K | $49.4K | ||||||||||
| Debt Instrument Decrease Forgiveness | $37.4K | ||||||||||||||
| Other Intangible Assets Net | $250.0K | $250.0K | $250.0K | $250.0K | |||||||||||
| Inventory Write Down | -$1.2K | ||||||||||||||
| Accounts Receivable Net | $1.8K | $1.8K | $1.8K | ||||||||||||
| Other Liabilities Current | $12.9K | $35.0K | $833.6K | $80.2K | $30.5K | ||||||||||
| Notes And Loans Payable Current | $53.1K | $4.7K | $6.4K | ||||||||||||
| Stock Issued During Period Value Conversion Of Preferred Stock | -$500.00 | ||||||||||||||
| Repayments Of Related Party Debt | $65.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.0M | -$534.3K | -$40.9K |
| Net Cash Provided By Used In Financing Activities | $1.1M | $317.5K | $266.6K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $125.4K | $34.5K | |
| Proceeds From Repayments Of Related Party Debt | -$30.5K | -$39.2K | |
| Proceeds From Related Party Debt | $1.1M | $42.6K | $37.0K |
| Increase Decrease In Accounts Receivable | $1.8K | -$30.0K | $30.0K |
| Payments To Acquire Property Plant And Equipment | $90.9K | ||
| Net Cash Provided By Used In Investing Activities | -$90.9K | ||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | |||
| Proceeds From Issuance Of Common Stock | $216.2K | $229.5K | |
| Increase Decrease In Accounts Payable | $8.8K | $2.1K | |
| Increase Decrease In Prepaid Expense | $4.1K | $5.9K | |
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Value | |||
| Share Based Compensation | $174.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$45.6K | -$164.8K | -$73.0K | ||||
| Net Cash Provided By Used In Financing Activities | $168.7K | $225.4K | $45.7K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$46.6K | -$6.8K | |||||
| Proceeds From Repayments Of Related Party Debt | $10.0K | $225.4K | |||||
| Proceeds From Related Party Debt | $158.7K | $550.00 | |||||
| Increase Decrease In Accounts Receivable | -$10.0K | ||||||
| Payments To Acquire Property Plant And Equipment | $41.5K | ||||||
| Net Cash Provided By Used In Investing Activities | -$41.5K | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $38.0K | $28.5K | $19.0K | $9.5K | $3.2K | ||
| Proceeds From Issuance Of Common Stock | $110.2K | ||||||
| Increase Decrease In Accounts Payable | $15.9K | $5.0K | |||||
| Increase Decrease In Prepaid Expense | -$1.8K | ||||||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Value | $20.4K | $109.2K | |||||
| Share Based Compensation |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 27.7M | 26.1M | 452.5M |
| Common Stock Shares Outstanding | 27.7M | 107.6M | |
| Common Stock Shares Authorized | 295.0M | 295.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | |
| Earnings Per Share Diluted | $-0.05 | $-0.02 | $0.00 |
| Earnings Per Share Basic | $-0.05 | $-0.02 | $0.00 |
| Common Stock Shares Issued | 27.7M | 107.6M | |
| Preferred Stock Shares Authorized | 5.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | ||
| Preferred Stock Shares Issued | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 28.0M | 27.7M | 27.7M | 27.7M | 27.7M | 27.7M | 109.1M | 108.6M | 108.5M | 266.2K | 313.6K | |||
| Common Stock Shares Outstanding | 28.0M | 27.9M | 27.7M | 27.7M | 27.7M | 27.7M | 27.7M | 109.1M | 108.6M | 266.2K | ||||
| Common Stock Shares Authorized | 295.0M | 295.0M | 295.0M | 295.0M | 295.0M | 295.0M | 295.0M | 1.00B | 295.0M | 295.0M | 1.00B | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Earnings Per Share Diluted | $-0.02 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $0.00 | $0.00 | |||||
| Earnings Per Share Basic | $-0.02 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Issued | 28.0M | 27.9M | 27.7M | 27.7M | 27.7M | 27.7M | 27.7M | 109.1M | 108.6M | 266.2K | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 500.0K | 500.0K | 500.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Additional Paid In Capital | $1.3M | $1.0M | |
| Security Deposit | $9.0K | ||
| Interest Paid Net | $41.8K | $495.00 | |
| Intellectual Property | $9.7M | ||
| Depreciation And Amortization | $263.3K | $5.8K | |
| Stock Issued During Period Value Conversion Of Convertible Securities | -$140.5K | ||
| Accumulated Amortization | |||
| Stock Issued During Period Value Conversion Of Units | -$10.1M | ||
| Foreign Currency Transaction Gain Loss Before Tax | -$53.00 | $191.00 | |
| Stock Issued During Period Value New Issues | $216.2K | ||
| Stock Issued During Period Value Conversion Of Acquiree Interest | |||
| Noncompete Agreement Net | $4.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $12.4M | $12.3M | $11.5M | $11.5M | $20.5M | $1.3M | $1.3M | $1.3M | $1.2M | ||
| Security Deposit | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | ||||||
| Interest Paid Net | $41.4K | ||||||||||
| Intellectual Property | $9.7M | $9.7M | $9.7M | $9.7M | |||||||
| Depreciation And Amortization | $259.1K | $2.5K | |||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $750.0K | -$500.00 | |||||||||
| Accumulated Amortization | -$998.5K | -$748.9K | -$499.3K | -$249.6K | |||||||
| Stock Issued During Period Value Conversion Of Units | -$10.1M | ||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$53.00 | $77.00 | |||||||||
| Stock Issued During Period Value New Issues | $106.0K | $110.2K | |||||||||
| Stock Issued During Period Value Conversion Of Acquiree Interest | -$140.5K | ||||||||||
| Noncompete Agreement Net |
Most recent annual filing with the SEC: May 22, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.